Please login to the form below

Not currently logged in
Email:
Password:
PMLiVE Top Pharma List

11

Revenue 2017

AstraZeneca

The Top Pharma List rankings are compiled from GlobalData's pharmaceutical revenue figures, which are based on prescription medicine sales, including generics drugs. They have been compiled below into an infographic of AstraZeneca's 2013 sales performance.

Astra Zeneca

HIV in View

by Real Chemistry for AstraZeneca. ... Breaking the Dangerous Cycle of Over-reliance on SABA Inhalers - by Real Chemistry for AstraZeneca.

Nucleus Global Diversity, Inclusion and Belonging

- - PMLiVE - PMLiVE

Dysphagia is Hard to Swallow

Sponsored by. by Real Chemistry for AstraZeneca. ... Breaking the Dangerous Cycle of Over-reliance on SABA Inhalers - by Real Chemistry for AstraZeneca.

Time To Unite

by Astrazeneca. ... beatingCOVID: Engaging employees during challenging times; Emerging strong from the pandemic - by Astrazeneca.

SMA: A Race Against Time

by Real Chemistry for AstraZeneca. ... Breaking the Dangerous Cycle of Over-reliance on SABA Inhalers - by Real Chemistry for AstraZeneca.

[ Previous 5 results ] 1 2 3 4 5 6 7 8 9 10 [ Next 5 results ]

COVID-19 Updates and Daily News

Featured jobs

PMHub

Add my company
Redbow Consulting Group

Redbow Consulting Group is a specialist healthcare management consultancy specialising in business strategy and marketing...

Latest intelligence

The Patient Will See You Now – The Evolution of the Doctor-Patient Relationship
The doctor-patient relationship is an ever changing one that changes as society changes. Technology then helps to drive this change along with a wide number of other factors....
Mind the Gap – Challenging Immunisation Apathy and Misinformation
world, the biggest challenges remain apathy and misinformation. Since a measles vaccine was introduced in the UK in 1968, Public Health England estimates that 20 million measles cases and 4,500...
Towards Better HCP Engagement – An Email Masterclass
6% of HCPs prefer being contacted by email, compared to 17% who favour the second most popular option: direct interaction with reps....